Curis
CRIS
#10248
Rank
โ‚น1.23 B
Marketcap
โ‚น95.82
Share price
-6.96%
Change (1 day)
-63.38%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น328.66. In 2024 the company made an earnings per share (EPS) of -โ‚น629.55 an increase over its 2023 EPS that were of -โ‚น808.65.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-49.82%
2024-โ‚น629.55-22.15%
2023-โ‚น808.65-26.17%
2022-โ‚น1,09522.3%
2021-โ‚น895.52-25.37%
2020-โ‚น1,200-30.93%
2019-โ‚น1,737-2.02%
2018-โ‚น1,773
2016-โ‚น4,030-10%
2015-โ‚น4,478138.1%
2014-โ‚น1,88140%
2013-โ‚น1,343-25%
2012-โ‚น1,79166.67%
2011-โ‚น1,075

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
โ‚น213.13-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น126.27-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.24-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น302.69-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.03-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น265.97-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,007 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA